Intuitive Surgical (ISRG) is a richly valued magnificent growth stock I last reviewed in this January 17, 2024 post following the January 9, 2024 release of certain unaudited preliminary Q4 and FY2023 financial results. In addition, it presented to the investment community at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024. Now [...]
I last reviewed RTX Corporation (RTX) in this October 29, 2023 post at which time it had just released its Q3 and YTD 2023 results. After reviewing the Q4 and FY2023 results and FY2024 outlook, I conclude RTX Corporation's valuation is not justified. When I completed my 2023 Year End FFJ Portfolio Review, RTX was [...]
Lockheed Martin (LMT) is advancing 21st Century security. This is one reason why it was my 7th largest holdings when I completed my 2023 Year End FFJ Portfolio Review; I hold shares in one of the 'Core' accounts within the FFJ Portfolio. In addition, LMT benefits from the U.S. Department of Defense and U.S. federal [...]
I am looking to increase exposure to Intuitive Surgical (ISRG) and its robust growth potential; it was my 15th largest holding when I completed my 2023 Year End FFJ Portfolio Review. In addition, it is currently the largest holding in a portfolio held by a young investor I am helping on their journey to [...]
I last reviewed BlackRock (BLK) in this October 15, 2023 post at which time I stated this is an asset manager in which to invest if you want exposure to the asset management industry. On January 12, 2024, BLK: released its Q4 and FY2023 results; and announced the proposed acquisition of Global Infrastructure Partners, a [...]
On December 19, I published Create Wealth With A Long Term HEICO Investment on this site. Dividend Power subsequently requested I also cover HEICO in a guest post; it is accessible here. For the sake of full disclosure, HEI.a was my 25th largest holding when I completed my 2023 Year End FFJ Portfolio Review. In [...]
In this brief post I disclose minor changes to investment holdings after publishing my 2023 Year End FFJ Portfolio Review. The changes were made as part of our Registered Retirement Savings Plan (RRSP) meltdown strategy. I do not disclose details surrounding our investment holdings in registered accounts, and therefore, make no mention of how many [...]
In my August 23 Zoom Video Communications (ZM) post, I disclosed my rationale for initiating a position in this company. Part of my analysis included a review of ZM's proxy. On Page 16, I noted that one of the continuing Directors (Peter Gassner) is the CEO and a member of the board of directors of [...]
Even if we invest in a great company, not every investment decision we make ends up being a wise one. We should, however, at least give ourselves a fighting chance of generating a decent investment return. Case in point? Nike (NKE). Pay attention to Nike's valuation otherwise you risk disappointment. NKE is a great company [...]
Paychex (PAYX) should appeal to risk-averse investors given its strong recurring revenue, and operating and free cash flow. I last reviewed it in this September 28 post at which time it had just released Q1 2024 results and raised its FY2024 outlook for the adjusted diluted EPS and Interest on Funds Held for Clients metrics. [...]